Ovarian cancer in the elderlyPIGNATA, Sandro; VERMORKEN, Jan B.Critical reviews in oncology/hematology. 2004, Vol 49, Num 1, pp 77-86, issn 1040-8428, 10 p.Article

Pegylated liposomal doxorubicin combined with carboplatin: A rational treatment choice for advanced ovarian cancerPIGNATA, Sandro; PUJADE LAURAINE, Eric; DU BOIS, Andreas et al.Critical reviews in oncology/hematology. 2010, Vol 73, Num 1, pp 23-30, issn 1040-8428, 8 p.Article

Cyclo-oxygenase inhibition in colorectal adenomas and cancerRICCHI, Paolo; PIGNATA, Sandro; LAFFAIOLI, Rosario Vincenzo et al.Journal of clinical gastroenterology. 2003, Vol 37, Num 4, pp 281-287, issn 0192-0790, 7 p.Article

Hepatocellular carcinoma: Systemic treatmentsDI MAIO, Massimo; DE MAIO, Ermelinda; PERRONE, Francesco et al.Journal of clinical gastroenterology. 2002, Vol 35, Num 5, pp S109-S114, issn 0192-0790, SUP2Article

Regulatory T cells, interleukin (IL)-6, IL-8, Vascular endothelial growth factor (VEGF), CXCL10, CXCL11, epidermal growth factor (EGF) and hepatocyte growth factor (HGF) as surrogate markers of host immunity in patients with renal cell carcinomaPOLIMENO, Marianeve; NAPOLITANO, Maria; LONGO, Nicola et al.BJU international (Papier). 2013, Vol 112, Num 5, pp 686-696, issn 1464-4096, 11 p.Article

Early Decline in Cancer Antigen 125 as a Surrogate for Progression-Free Survival in Recurrent Ovarian CancerLEE, Chee K; FRIEDLANDER, Michael; RAZA MIRZA, Mansoor et al.Journal of the National Cancer Institute. 2011, Vol 103, Num 17, pp 1338-1342, issn 0027-8874, 5 p.Article

A phase II study of weekly carboplatin and paclitaxel as first-line treatment of elderly patients with advanced ovarian cancer A Multicentre Italian Trial in Ovarian cancer (MITO-5) studyPIGNATA, Sandro; BREDA, Enrico; PERRONE, Francesco et al.Critical reviews in oncology/hematology. 2008, Vol 66, Num 3, pp 229-236, issn 1040-8428, 8 p.Article

Activity of chemotherapy in mucinous epithelial ovarian cancer : A retrospective studyPISANO, Carmela; GREGGI, Stefano; PIGNATA, Sandro et al.Anticancer research. 2005, Vol 25, Num 5, pp 3501-3505, issn 0250-7005, 5 p.Article

Prognostic value of Serum biological markers in patients with hepatocellular carcinomaPARASOLE, Rosanna; IZZO, Francesco; GALLO, Ciro et al.Clinical cancer research. 2001, Vol 7, Num 11, pp 3504-3509, issn 1078-0432Article

Carboplatin, cisplatin and paclitaxel in the treatment of patients with epithelial ovarian cancerDE PLACIDO, Sabino; TRAMONTANA, Sergio; PIGNATA, Sandro et al.Anticancer research. 2000, Vol 20, Num 5C, pp 4023-4029, issn 0250-7005Article

Current knowledge and open issues regarding Bevacizumab in gynaecological neoplasmsBELLATI, Filippo; NAPOLETANO, Chiara; LUISA GASPARRI, Maria et al.Critical reviews in oncology/hematology. 2012, Vol 83, Num 1, pp 35-46, issn 1040-8428, 12 p.Article

Pegylated Liposomal Doxorubicin and Carboplatin Compared With Paclitaxel and Carboplatin for Patients With Platinum-Sensitive Ovarian Cancer in Late RelapsePUJADE-LAURAINE, Eric; WAGNER, Uwe; SEHOULI, Jalid et al.Journal of clinical oncology. 2010, Vol 28, Num 20, pp 3323-3329, issn 0732-183X, 7 p.Article

Can Hepatocellular Cancer Screening Increase the Proportion of Long-Term Survivors?GANNON, Christopher J; IZZO, Francesco; ALOIA, Thomas A et al.Hepato-gastroenterology. 2009, Vol 56, Num 93, pp 1152-1156, issn 0172-6390, 5 p.Article

Phase III Trial of Gemcitabine Compared With Pegylated Liposomal Doxorubicin in Progressive or Recurrent Ovarian CancerFERRANDINA, Gabriella; LUDOVISI, Manuela; SCAMBIA, Giovanni et al.Journal of clinical oncology. 2008, Vol 26, Num 6, pp 890-896, issn 0732-183X, 7 p.Article

Inhibitory effects of anti-CXCR4 antibodies on human colon cancer cellsOTTAIANO, Alessandro; DI PALMA, Antonella; IAFFAIOLI, Rosario Vincenzo et al.Cancer immunology and immunotherapy. 2005, Vol 54, Num 8, pp 781-791, issn 0340-7004, 11 p.Article

The role of chemotherapy in locally advanced, metastatic and recurrent cervical cancerTAMBARO, Rosa; SCAMBIA, Giovanni; DI MAIO, Massimo et al.Critical reviews in oncology/hematology. 2004, Vol 52, Num 1, pp 33-44, issn 1040-8428, 12 p.Article

Efficacy and safety results from OCTAVIA, a single-arm phase II study evaluating front-line bevacizumab, carboplatin and weekly paclitaxel for ovarian cancerGONZALEZ-MARTIN, Antonio; GLADIEFF, Laurence; PIGNATA, Sandro et al.European journal of cancer (1990). 2013, Vol 49, Num 18, pp 3831-3838, issn 0959-8049, 8 p.Article

Carboplatin Plus Paclitaxel Versus Carboplatin Plus Pegylated Liposomal Doxorubicin As First-Line Treatment for Patients With Ovarian Cancer: The MITO-2 Randomized Phase III TrialPIGNATA, Sandro; SCAMBIA, Giovanni; VERNAGLIA LOMBARDI, Alessandra et al.Journal of clinical oncology. 2011, Vol 29, Num 27, pp 3628-3635, issn 0732-183X, 8 p.Article

Use of Adjuvant Therapy in Patients with FIGO Stage III Endometrial Carcinoma: A Multicenter Retrospective StudyMARCHETTI, Claudia; PISANO, Carmela; PIGNATA, Sandro et al.Oncology. 2011, Vol 81, Num 2, pp 104-112, issn 0030-2414, 9 p.Article

Characteristics at presentation and outcome of hepatocellular carcinoma (HCC) in the elderly A study of the cancer of the liver italian program (CLIP)PIGNATA, Sandro; GALLO, Ciro; DEL NAJA, Carlo et al.Critical reviews in oncology/hematology. 2006, Vol 59, Num 3, pp 243-249, issn 1040-8428, 7 p.Article

First-line chemotherapy with fluorouracil and folinic acid for advanced Colorectal cancer in elderly patients: A phase II studyDANIELE, Bruno; ROSATI, Gerardo; PERRONE, Francesco et al.Journal of clinical gastroenterology. 2003, Vol 36, Num 3, pp 228-233, issn 0192-0790, 6 p.Article

Transcatheter arterial procedures in the treatment of patients with hepatocellular carcinoma: a review of literatureDE MAIO, Ermelinda; FIORE, Francesco; DANIELE, Bruno et al.Critical reviews in oncology/hematology. 2003, Vol 46, Num 3, pp 285-295, issn 1040-8428, 11 p.Article